Investigational 2022

2 papers

Top Research Directions

The 1 research directions with Investigational 2022 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Overcoming Systemic Toxicity in Cancer Immunotherapy150.0%

Download all directions as CSV

Institutions

Institutions credited by Investigational 2022 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare
1Sichuan University 1100.0%

Download all institutions as CSV

About this data

Papers. Investigational 2022 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 2 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-18 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Investigational 2022”, https://lacuna.tiptreesystems.com/venue/investigational/2022.

Papers

Title
A small molecule inhibitor of VSIG-8 prevents its binding to VISTA
Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma